November 2023 - Page 7 of 16

ThursdayNov 16, 2023 9:45 am

Clene Inc. (NASDAQ: CLNN) Reports Q3 2023 Financial Results, Recent Operating Highlights for Its ALS Clinical Program

Clene recently released its financial results for the third quarter ended September 30, 2023, and provided recent operating highlights for its ALS clinical program The ALS clinical program includes two independent studies evaluating the safety and efficacy of the company’s lead investigational product CNM-Au8(R) The 24-month long-term data cut from the open-label extension of the RESCUE-ALS study showed a significant median survival benefit of 19.3 months, a significant 52% decreased risk of ALS clinical worsening events, and a 75% decreased risk of long-term all-cause mortality Clene also summarized long-term follow-up data from the HEALEY ALS platform trial, which demonstrated significantly…

WednesdayNov 15, 2023 3:46 pm

QualityStocksNewsBreaks – NextPlat Corp.’s (NASDAQ: NXPL) Strong Growth Featured in Proactive Podcast

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, was featured in an interview with Proactive, where its CEO Charlie Fernandez joined host Steve Darling to provide an update on the company’s latest financial results. NextPlat has made impressive strides in consolidating its global e-commerce and Progressive Care health care operations, leading to significant growth. During the interview, Fernandez highlighted the company’s strong financial performance in the third quarter, reporting consolidated revenues of $15.3 million. This represents a remarkable >481% increase compared to the third quarter of the previous year. In addition, the company’s gross margins saw substantial improvement, reaching 30%…

WednesdayNov 15, 2023 3:25 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Advance Patented DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is steadily advancing its patented DehydraTECH(TM) technology for a growing range of applications including oral nicotine, hypertension, antivirals, human hormone therapy, diabetes and more. Through previous clinical trials, DehydraTECH-processed CBD has shown its ability to lower blood pressure in patients over multiple weeks. “That we were able to lower blood pressure in our patient population over multiple weeks using DehydraTECH-CBD is an exceptional discovery, given that previous studies by others using other oral CBD formulations have failed to evidence this sustained benefit,” a recent article quotes Lexaria CEO…

WednesdayNov 15, 2023 2:26 pm

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) to Effect Reverse Stock Split

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. According to the announcement, the reverse stock split will become effective at 4:01 p.m., Eastern Time, on Nov. 16, 2023. The company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol SNES and will begin trading on a split-adjusted basis when the market opens on Nov. 17, 2023. At a special meeting held on Aug.…

WednesdayNov 15, 2023 1:39 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Successful Quantum Error Mitigation Results in Advantage2(TM) Prototype

D-Wave (NYSE: QBTS) is a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers. The company has announced important research results that demonstrate successful Quantum Error Mitigation (“QEM”) in its Advantage2(TM) annealing quantum computing experimental prototype. According to the announcement, the techniques reduce errors in quantum simulations, producing results consistent with the quantum system maintaining its quantum state (“coherence”) for an order of magnitude longer time than an unmitigated system. D-Wave expects to leverage these techniques to drive performance advancements in the forthcoming Advantage2 system and future processors. “Errors represent the most significant…

WednesdayNov 15, 2023 1:15 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Strong Preliminary Earnings for Q3

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has released its preliminary financial results for the third quarter of 2023. Among the highlights, the company reported annualized revenue growth of 27% quarter over quarter and a margin increase of 27% year over year. “We had another quarter of strong growth and improved profitability at a time when a number of large players in the freight market are facing severe…

WednesdayNov 15, 2023 1:11 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Launches SekurRelay Enterprise Email Solution

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss hosted secure and private communications platform, today announced the launch of its SekurRelay Enterprise Email Solution, allowing corporate executives and management to “split” their company email domain. This enables companies to benefit from SekurMail’s SekurSend/SekurReply feature and other Swiss-hosted privacy and security solutions SekurMail offers without having to migrate all employees, eliminating a huge roadblock to mass adoption of SekurMail by large corporations and government agencies. “We are excited to provide SekurRelay to our customers as it provides protection from BEC attacks to C-level executives and managers who…

WednesdayNov 15, 2023 1:05 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q3 2023 Financial Results, Update on Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting on its financial results for third quarter, the period ended Sept. 30, 2023; the company also noted upcoming milestones. Notable financial numbers from the report include net loss for Q3 totaled approximately $4.5 million compared to an estimated $3.4 million for the comparable period in 2022; R&D expenses came in at $3.4 million for the third quarter compared to approximately $2.2 million for the comparable period in 2022; and general and administrative…

WednesdayNov 15, 2023 12:53 pm

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) CEO Talks Bridging Gap Between Traditional Market and Future of Digital Securities on Benzinga’s All-Access

Diamond Lake Minerals (OTC: DLMI), which specializes in the development and support of digital assets and SEC-registered security tokens, was featured on Benzinga’s All-Access. Diamond Lake’s CEO Brian Esposito joined the program to discuss his vision for the company and DLMI’s “old-school” approach to running a business: focusing on the balance sheet, increasing profits and wealth enhancement. “I’ve been honored to take over as CEO of Diamond Lake Minerals in August. What we are doing is bridging the traditional securities market with the future of digital securities. So, I’d like to look at us like an old school General Electric…

WednesdayNov 15, 2023 12:25 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q3 2023 Financial Report, Operational Update

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, allowing for the creation of rich data for artificial intelligence (“AI”), is reporting its financial and operational results for the third quarter ended Sept. 30, 2023. Highlights of the report include the publication of a foundational study demonstrating the ability of HeartBeam’s VECG technology platform to detect the presence of coronary artery occlusions in the “Journal of American College Cardiology”; several new management and board of director appointments; and significant progress made toward key milestones…

Site Search

Company Search

Month: November 2023